Correspondence 0001013762-24-001592 from PURPLE BIOTECH LTD. (PPBT)
PURPLE BIOTECH LTD.
Date: July 26, 2024 · CIK: 0001614744 · Accession: 0001013762-24-001592
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280947
Letter
Purple Biotech Ltd.
4 Oppenheimer Street, Science Park
Rehovot 7670104, Israel
July 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street N.E.
Washington, D.C. 20549
Attention: Alan Campbell
Re: Purple Biotech Ltd.
Registration Statement on Form F-1
Filed July 22, 2024
File No. 333-280947 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Purple Biotech Ltd. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement be accelerated by the Securities and Exchange Commission to 4:05 p.m., Eastern Time on July 30, 2024, or as soon thereafter as practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to the Company’s counsel, Haynes and Boone, LLP, by calling Alla Digilova at (212) 659-4993, and that such effectiveness also be confirmed in writing.
Very truly yours,
Purple Biotech Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Purple Biotech Ltd.
4 Oppenheimer Street, Science Park
Rehovot 7670104, Israel
July 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street N.E.
Washington, D.C. 20549
Attention: Alan Campbell
Re: Purple Biotech Ltd.
Registration Statement on Form F-1
Filed July 22, 2024
File No. 333-280947 (the “Registration
Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended, Purple Biotech Ltd. (the “Company”)
hereby respectfully requests that the effective date of the Company’s Registration Statement be accelerated by the Securities
and Exchange Commission to 4:05 p.m., Eastern Time on July 30, 2024, or as soon thereafter as practicable.
The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to the Company’s counsel, Haynes and Boone,
LLP, by calling Alla Digilova at (212) 659-4993, and that such effectiveness also be confirmed in
writing.
Very truly yours,
Purple Biotech Ltd.
By:
/s/ Gil Efron
Gil Efron
Chief Executive Officer
cc:
Rick A. Werner, Esq., Haynes and Boone, LLP
Alla Digilova, Esq., Haynes and Boone, LLP